Valuation: Cegedim

Market Cap 147M 169M 137M 126M 237M 16.1B 240M 1.61B 630M 8.06B 636M 622M 26.68B P/E 2026 *
7x
P/E 2027 * 5.34x
Enterprise Value 309M 357M 288M 265M 500M 33.9B 505M 3.38B 1.33B 16.96B 1.34B 1.31B 56.18B EV / Sales 2026 *
0.47x
EV / Sales 2027 * 0.41x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
1 day-13.33%
1 week+19.82%
Current month+19.35%
1 month+15.28%
3 months+1.25%
6 months-8.65%
Current year-9.33%
1 week 10.18
Extreme 10.18
12.15
1 month 10.12
Extreme 10.12
12.15
Current year 8.6
Extreme 8.6
14.8
1 year 8.6
Extreme 8.6
14.8
3 years 8.6
Extreme 8.6
21.2
5 years 8.6
Extreme 8.6
29
10 years 8.6
Extreme 8.6
42.5
Manager TitleAgeSince
Chief Executive Officer 83 25/10/2009
Director of Finance/CFO - 14/06/2016
Corporate Officer/Principal 55 26/11/2015
Director TitleAgeSince
Chairman 83 25/10/2009
Director/Board Member 72 09/08/2010
Director/Board Member 55 26/10/2009
Change 5-day change 1-year change 3-year change Capi.($)
-56.91%+19.82% - - 166M
-0.93%+22.63%-43.52%+24.37% 420B
+1.12%+6.29%-30.84%+39.24% 222B
-0.78%+1.26%-35.25%+5.62% 122B
-2.47%+0.91%-34.35%+16.29% 48.59B
+0.74%+5.40%-73.80%+165.28% 37.52B
+4.26%-20.50%-18.73%+26.74% 22.61B
+2.93%+6.75%-27.06%+70.84% 19.6B
-2.06%+0.58%-29.17%+6.37% 13.94B
+0.01%-4.14%-28.12%+88.80% 13.35B
Average -1.43%+3.07%-35.65%+49.28% 102.23B
Weighted average by Cap. -0.74%+11.98%-38.71%+32.51%

Financials

2026 *2027 *
Net sales 660M 762M 615M 565M 1.07B 72.41B 1.08B 7.22B 2.84B 36.23B 2.86B 2.8B 120B 684M 790M 638M 586M 1.11B 75.1B 1.12B 7.49B 2.94B 37.58B 2.97B 2.9B 124B
Net income 21.3M 24.59M 19.86M 18.26M 34.48M 2.34B 34.86M 233M 91.58M 1.17B 92.37M 90.33M 3.88B 28M 32.33M 26.1M 24.01M 45.32M 3.07B 45.83M 307M 120M 1.54B 121M 119M 5.09B
Net Debt 162M 187M 151M 139M 262M 17.8B 265M 1.78B 697M 8.91B 703M 688M 29.5B 134M 154M 125M 115M 216M 14.68B 219M 1.47B 575M 7.35B 580M 567M 24.33B
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
6,344
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
10.68EUR
Average target price
15.50EUR
Spread / Average Target
+45.13%

Quarterly revenue - Rate of surprise